SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Peter Silsbee who wrote (3225)12/8/1997 2:06:00 PM
From: Steve Fancy   of 6136
 
Hi Peter, PMFJI but there are a handfull of folks that I believe are extremely overextended with AGPH who are having a hard time with the likely reality that the 12 month price target will fall somewhere between the Lehman (46) and PW (65-70) price targets...probably leaning closer to Lehman's. I own more AGPH than I care to admit, and am disappointed also, but I learned a long time ago not to put all my eggs in one basket.

In any case a couple of folks here become very hostile at any evidence, or suggested evidence against AGPH. I agree it's becoming very old, and out of hand to the point that I believe many lurkers wouldn't post potential negative news that informed investors need to know due to the potential attacks on credibility that seem to follow.

This is not constructive at all, and I like you appreciate all news posted here. You can generally see right through people trying to influence the stock due to their own agenda's if properly informed.

If the negativity towards constructive information continues, I may attempt to start another thread for investors as opposed to those married to the stock.

sf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext